AROMASIN may prevent recurrence and breast cancer

Aromasin pills
Photo ? Karl Stephan

AROMASIN (exemestane) can prevent new cases of breast cancer, as well as recurrence in postmenopausal women. ?'ll be glad to know that exemestane be soon available in generic form, as the patent expired on 1 April. ? that would make for a medicine of lower cost which reduces the number of newly diagnosed breast cancers.

This news is the result of a study carried out by the NCIC clinical trials group at the University of the Queen in Ontario, Canada. ? the results of the study were presented at this year's meeting of the American Society of Clinical Oncology in Chicago. The New England Journal of Medicine published the study, which lasted 5 years and included more than 4,500 women living in United States, Spain, and? France. ? women in this study were already menopause and they were identified as at high risk for breast cancer.

This is the first time that has been considered a hormone therapy as quimioprevención of breast cancer. ? tamoxifen has not been widely prescribed for many pre-and postmenopausal women after breast cancer. ? sensitive treatment to estrogen prevents the return of breast cancer by blocking the estrogen receptor, but does not stop estrogen production. ? the downside of tamoxifen, and the reason why many patients are not so taken five years which is the standard regime, the effects. ? of tamoxifen side causes menopause such as hot flashes, sweats and increases the risk of cancers of the endometrium, falls and stroke at night.

AROMASIN is milder effects than tamoxifen and works differently. ? estrogen of blocks of tamoxifen and Aromasin prevents that estrogen production. ? Aromasin is an inhibitor of aromatase, often given to patients of breast cancer postmenopausal who have completed treatment for cancer. ? of drugs or estrogen-sensitive breast would benefit patients with tumors of breast estrogen receptor negative, as Triple negative breast cancer (Purple).

Not to go and ask your doctor to prescribe exemestane such as breast cancer prevention yet. ? that more studies will only be done in their benefits and risks, as well as its effectiveness to prevent the development of tumors of the breast in women at high risk. ? But if the research holds, this drug can prevent many preventive youth mastectomies and older women who have had genetic testing and found themselves with a strong family history, as well as a genetic predisposition for breast cancer. ? for women who do not mind a case principle of hot flashes in order to avoid a breast tumor, the side effects of exemestane does not seem too bad.

View the original article here